Stephen Garbacz

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA.

Part of Smith & Nephew plc, Smith & Nephew Endoscopy, Inc. develops medical technology products used principally in tissue, bone, skin, and soft tissue repair. The company is based in Andover, MA.

Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA.

Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA.

Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA.

Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation.

Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018.

Arthrosurface, Inc. engage sin the design and distribution of orthopedic devices for joint preservation, restoration, and resurfacing. It offers HemiCAP system that can be use to treat a variety of joint conditions caused by trauma, injury, and disease. The company was founded by Steven W. Ek, Andrea Patisteas, and Steven J. Tallarida in 2002 and is headquartered in Franklin, MA.

Hyalex Orthopaedics, Inc. manufactures medical devices. The firm focus on developing and commercializing new products that feature HYALEX materials technology, a synthetic polymer that mimics cartilage. Its synthetic HYALEX material has the capability of maintaining low friction and low wear under the high loads encountered in human joints. The company is headquartered in Lexington, MA.

Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.

Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach.

Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. engages in the manufacture of pharmaceutical products. The company was founded on April 14, 1999 and is headquartered in Guangzhou, China.

BeiGene (Guangzhou) Co., Ltd. engages in the research and development of biotechnology and pharmaceutical products. The company was founded on July 11, 2017 and is headquartered in Guangzhou, China.

BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA.

Primo Medical Group, Inc. designs and manufactures medical devices and precision machined components. It offers outsourcing solutions to the medical device market, including OEM product distribution services, engineering services, precision component production and finished goods assembly, refurbishment of medical devices, reusable surgical kit management and complete supply chain management. The company was founded in 1953 by Primo Tallarida and is headquartered in Stoughton, MA.

Linvatec Corp. provides advanced electrosurgical systems and electrocardiogram electrodes and accessories. The company's products include polymer implants, such as screws, pins, and meniscal implants used in various orthopedic procedures. In addition, it offers battery, pneumatic, and electric-powered surgical instruments, which are used in open orthopedic surgery and other surgical applications, including oral, maxillofacial, ENT, otolaryngology, podiatry, thoracic hand, cardiology, and neurosurgery. The company's products, such as arthroscopic instrumentation, implants, fixation, tissue repair systems serve orthopedic surgeons for diagnostic purposes, minor surgeries and complex reconstructions of knees, shoulders and small joints, such as the wrist and ankle. It has operations in Tampere, Finland, California, and Oregon, as well as Canada, the United Kingdom, Spain, France, Germany, Belgium, South Korea, Australia, Austria, Poland, and the Netherlands. The company was founded in 1963 and is headquartered in Largo, FL.L.

Executive Leadership Council, Inc. operates as a preeminent member organization for the development of global black leaders. It increase the number of successful black executives both domestically and internationally by adding value to their development, leadership, and philanthropic endeavors throughout the life-cycle of their careers thereby strengthening their companies, organizations and communities. The company was founded in 1986 and is headquartered in Alexandria, VA.

Resolve Surgical Technologies, Inc. develops and manufactures medical devices. It provides products in the spine, biologics, orthopedics, and cardiothoracic markets. The company was founded in 1992 and is headquartered in Marquette, MI.